Physician Assistant, Medical · Wasilla, AK
NPI
1922498781
Since 2015
Specialty
Physician Assistant, Medical
Code 363AM0700X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
3331 E Meridian Park Loop
Wasilla, AK, 99654
Phone (907) 357-2332
Groups this clinician bills Medicare through
Medicare paid, 2024
$163K
2,698 services
Medicare patients, 2024
446
Average age 72
Drug cost, 2024
$2.8M
3,997 prescriptions
Company payments, 2025
$3,470
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Matthew Loudon was code 99214 (office e&m - established), 1,020 times for 376 patients. In total Matthew Loudon billed 2,698 services in 29 codes, and Medicare paid $163K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-02-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,020 | 376 | $93.39 | $95K |
| G0109 Diabetes outpatient self-management training services, group session (2 or more), per 30 minutes | Office | 442 | 33 | $15.69 | $6,933 |
| 95251 Test - Miscellaneous | Office | 379 | 178 | $29.01 | $11K |
| G0108 Diabetes outpatient self-management training services, individual, per 30 minutes | Office | 159 | 74 | $54.13 | $8,606 |
| 83036 Blood Count | Office | 138 | 122 | $9.38 | $1,295 |
| G6001 Ultrasonic guidance for placement of radiation therapy fields | Office | 74 | 33 | $133.51 | $9,880 |
| 77280 Radiation Treatment Planning | Office | 74 | 33 | $198.28 | $15K |
| 77401 Conventional Radiation Treatment | Office | 73 | 33 | $34.87 | $2,546 |
| 80053 Clinical Chemistry | Office | 64 | 64 | $10.35 | $662 |
| 36415 Venipuncture Blood Collection | Office | 63 | 63 | $8.65 | $545 |
| 99205 Office E&M - New | Office | 44 | 44 | $166.91 | $7,344 |
| 80061 Clinical Chemistry | Office | 41 | 41 | $13.12 | $538 |
| 82570 Clinical Chemistry | Office | 28 | 28 | $5.08 | $142 |
| 99211 Office E&M - Established | Office | 28 | 24 | $18.36 | $514 |
| 82043 Clinical Chemistry | Office | 28 | 28 | $5.66 | $158 |
By year: 2022 $119K for 3,986 services; 2023 $153K for 4,465 services; 2024 $163K for 2,698 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 138 | 122 | $9.38 | $1,295 |
| 80053 Clinical Chemistry | 64 | 64 | $10.35 | $662 |
| 36415 Venipuncture Blood Collection | 63 | 63 | $8.65 | $545 |
| 80061 Clinical Chemistry | 41 | 41 | $13.12 | $538 |
| 82043 Clinical Chemistry | 28 | 28 | $5.66 | $158 |
| 82570 Clinical Chemistry | 28 | 28 | $5.08 | $142 |
Medicare prescription drug claims, 2024
In 2024, the drug Matthew Loudon prescribed most often to Medicare patients was Ozempic (Semaglutide), with 299 prescriptions and refills. In total Matthew Loudon wrote 3,997 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 299 | 590 | 70 | $551K |
| Farxiga Dapagliflozin Propanediol | 180 | 490 | 63 | $259K |
| Glipizide Er Glipizide | 167 | 464 | 50 | $4,552 |
| Metformin Hcl Generic | 163 | 455 | 55 | $1,521 |
| Tresiba Flextouch U-100 Insulin Degludec | 150 | 339 | 57 | $136K |
| Tresiba Flextouch U-200 Insulin Degludec | 133 | 352 | 45 | $248K |
| Metformin Hcl Er Metformin Hcl | 122 | 335 | 43 | $1,390 |
| Trulicity Dulaglutide | 116 | 213 | 26 | $204K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 108 | 259 | 55 | $16K |
| Rosuvastatin Calcium Generic | 105 | 279 | 29 | $2,216 |
| Atorvastatin Calcium Generic | 105 | 291 | 35 | $1,795 |
| Lisinopril Generic | 101 | 302 | 33 | $883 |
| Xigduo Xr Dapaglifloz Propaned/Metformin | 99 | 241 | 28 | $129K |
| Jardiance Empagliflozin | 93 | 248 | 26 | $132K |
| Ezetimibe Generic | 83 | 219 | 21 | $2,402 |
Brand drugs: 2,066 claims; generic drugs: 1,627 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Matthew Loudon $3,470 ($3,470 in general payments such as food, travel and fees) from 11 companies. The largest payer was Insulet Corporation with $2,662.
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation PODD | 15 | $2,662 |
| Sanofi-Aventis U.S. LLC SNY | 7 | $288 |
| Amgen Inc. AMGN | 8 | $187 |
| Novo Nordisk Inc NVO | 5 | $130 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $49.77 |
| Abbott Laboratories ABT | 2 | $35.9 |
| Corcept Therapeutics CORT | 1 | $34.71 |
| Xeris Pharmaceuticals, Inc. | 1 | $25.49 |
| Lilly USA, LLC LLY | 1 | $21.29 |
| Abbvie Inc. ABBV | 1 | $18.39 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.